Skip to main content

Table 3 Total healthcare resource utilization and costs

From: Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study

Measure

12 month post period

24 month post period

Total Patients

761

272

  Inpatient Hospitalization

  

  Members with Hospitalization n,(%)

158 (20.8%)

85 (31.3%)

  Hospitalizations Per Member**

0.4 (± 0.9)

0.7 (± 1.4)

 

0 [0 - 6]

0 [0 - 8]

Emergency Room Visits

  

  Members with Visit n,(%)

236 (31.01%)

121 (44.49%)

  Visits Per Member**

0.6 (± 1.6)

1.3 (± 3.0)

 

0 [0 - 30]

0 [0 - 42]

Outpatient Visits

  

  Members with Visit n,(%)

760 (99.9%)

272 (100.0%)

  Visits Per Member**

35. (± 33.5)

68.6 (± 61.7)

 

25 [0 - 320]

53 [9 - 698]

Pharmacy Claims

  

  Members with Pharmacy Claim, n,(%)

761 (100.0%)

272 (100.0%)

  Pharmacy Claims Per Member**

45.99 (± 31.9)

98.60 (± 65.9)

 

39 [1 - 214]

83 [4 - 366]

Total Healthcare Cost**

$17,460 (± $33,437)

$30,292 (± $67,230)

 

$10,896 [$1,097 - $758,916]

$18,106 [$2,859 - $1,060,087]

  Inpatient Hospitalization Cost**

$4,585 (± $23,717)

$8,978 (± $48,891)

 

$0 [$0 - $562,430]

$0 [$0 - $774,152]

  Emergency Room Visit Cost**

$400 (± $2,433)

$855 (± $4,312)

 

$0 [$0 - $62,129]

$0 [$0 - $68,565]

  Outpatient Cost**

$5,713 (± $8,397)

$9,673 (± $12,448)

 

$2,724 [$0 - $91,816]

$6,067 [$0 - $144,264]

  Pharmacy Cost**

$6,762 (± $6,359)

$10,787 (± $10,996)

 

$4,253 [$829 - $72,703]

$6,343 [$855 - $73,434]

  1. **Mean, standard deviation, median, [range].